Results

1–10 of 897 results

Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
Updates from the Field
2021
Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results
David A. Eichenbaum, MD, FASRS
Updates from the Field
2021
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial
Peter A. Campochiaro, MD
Updates from the Field
2021
Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies
David M. Brown, MD
Updates from the Field
2021
Macular Hole Acrobatics: How do we close it up. There's always a way to do that. ILM Flaps
Prethy Rao, MD, MPH
Updates from the Field
2021
Varsity Level OCT: When you look at the retina, careful you must be. For the retina looks back
Caroline Baumal, MD
Updates from the Field
2021
I find your lack of faith disturbing: Handling Taruma as a Retinal Surgeon
Yewlin E Chee, MD
Updates from the Field
2021
This was not the medical retina you were looking for: Surgical Approaches in Medical Retina
Lejla Vajzovic, MD, FASRS
Updates from the Field
2021
Bringing Balance to the Force: Diversity, Equity and Inclusion
Basil K Williams, MD
Updates from the Field
2021